The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency.

MLA

Rupar, Nina, et al. “The CC2D2B Is a Novel Genetic Modifier of the Clinical Phenotype in Patients with Hereditary Angioedema Due to C1 Inhibitor Deficiency.” Gene, vol. 919, Aug. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.gene.2024.148496.

APA

Rupar, N., Šelb, J., Košnik, M., Zidarn, M., Andrejević, S., Čulav, L., Grivčeva, P. V., Korošec, P., & Rijavec, M. (2024). The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency. Gene, 919, N.PAG. https://doi.org/10.1016/j.gene.2024.148496

Chicago

Rupar, Nina, Julij Šelb, Mitja Košnik, Mihaela Zidarn, Slađana Andrejević, Ljerka Čulav, Panovska, Vesna Grivčeva, Peter Korošec, and Matija Rijavec. 2024. “The CC2D2B Is a Novel Genetic Modifier of the Clinical Phenotype in Patients with Hereditary Angioedema Due to C1 Inhibitor Deficiency.” Gene 919 (August): N.PAG. doi:10.1016/j.gene.2024.148496.